Additional proof the U.S. Food and Drug Administration continues to be warming up to contemporary technologies — it has only accepted the first continuous blood glucose monitor that doesn’t need the user to penis themselves over and over for a blood sample.
The FDA cleared Abbot’s FreeStyle Libre Flash Glucose Monitoring System, a device that uses a small sensor wire inserted to determine sugar levels in diabetics. Another apparatus is waved over the detector to measure and give a readout of those glucose levels.
This is a landmark move for the FDA as diabetes affects almost 30 million people in the USA who now have to check their blood sugar by pricking themselves a few times throughout the day and whenever they eat.
The idea for a prickless blood glucose screen rsquo, isn &fresh. Tech companies have shown an interest in the massive diabetics market over the previous couple of decades. Apple is rumored to be working on such a device and its CEO Tim Cook has even been seen sporting a possible prototype that could connect into the Apple Watch.
Other companies endeavor to build something similar, including Glucowise, which has a device still under development.
But it seems it’therefore not easy to make a blood glucose detector. Google attempted to build a contact lens that could detect glucose but it appears the job has gone nowhere since drug company Novartis licensed the technician in 2014. Still another FDA-approved device for sugar monitoring without the penis known as the GlucoWatch was accepted in the early 2000’therefore, but customers found it cumbersome and it occurred to cause a bad rash in certain.
However rsquo & there;s hope now that the Freestyle monitor has worked of the kinks out. The unit is intended for people 18 and older and, following a 12-hour startup interval, can be worn for up to ten days, according to a statement about the FDA’s site.
“The FDA is obviously interested in new technologies that can help to make the care of people living with chronic conditions, like diabetes, simpler and more manageable,” stated FDA spokesperson Donald St. Pierre. “for treating their diabetes — with a wave of the reader This program makes it possible for people with diabetics to prevent the additional measure of finger stick calibration, which may be painful, but provides information. ”
Read more: https://techcrunch.com